Novanta Announces $300 Million Private Share Placement
TipRanks (Tue, 9-Jun 6:39 PM ET)
4 stocks to watch on Tuesday: JBLU, GSK, PFE, NOVT
Seeking Alpha News (Tue, 9-Jun 8:58 AM ET)
Novanta to acquire Riverpoint Medical in $1.45B deal, raises $300M privately
Seeking Alpha News (Tue, 9-Jun 7:21 AM ET)
Novanta to Acquire Riverpoint Medical in Strategic Deal
TipRanks (Tue, 9-Jun 6:34 AM ET)
Novanta Inc. Announces $300 Million Private Placement
Business Wire (Tue, 9-Jun 6:15 AM ET)
Novanta Inc. Announces Acquisition of Riverpoint Medical
Business Wire (Tue, 9-Jun 6:00 AM ET)
Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
Business Wire (Fri, 15-May 4:27 PM ET)
Business Wire (Fri, 15-May 4:05 PM ET)
Novanta Announces Financial Results for the First Quarter 2026
Business Wire (Mon, 11-May 4:45 PM ET)
Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
Business Wire (Tue, 14-Apr 11:00 AM ET)
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Novanta - Common Shares trades on the NASDAQ stock market under the symbol NOVT.
As of June 12, 2026, NOVT stock price declined to $160.53 with 443,899 million shares trading.
NOVT has a beta of 1.92, meaning it tends to be more sensitive to market movements. NOVT has a correlation of 0.24 to the broad based SPY ETF.
NOVT has a market cap of $5.72 billion. This is considered a Mid Cap stock.
Last quarter Novanta - Common Shares reported $258 million in Revenue and $.81 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.03.
In the last 3 years, NOVT traded as high as $187.61 and as low as $98.27.
The top ETF exchange traded funds that NOVT belongs to (by Net Assets): IJH, VTI, IWM, VGT, VB.
NOVT has outperformed the market in the last year with a price return of +25.6% while the SPY ETF gained +24.6%. NOVT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.1% and +0.8%, respectively, while the SPY returned +9.9% and -1.7%, respectively.
NOVT support price is $157.02 and resistance is $167.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVT shares will trade within this expected range on the day.